A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults

NCT05167526 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
36
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to protocol defined stopping criteria being met.

Conditions

Interventions

Sponsor

Astellas Pharma Global Development, Inc.